After $3 million worth of Kratom is seized, FDA continued to warn of its dangers
In an import warning that has been in effect for many years, the FDA has determined that Kratom and dietary supplements containing this herb are adulterated.
Mithragina, commonly known as Kratom, is a plant that grows as a shrub or small tree. It is native to Thailand, Malaysia, Indonesia, and Papua New Guinea. In recent years, this plant has gained a following due to its alleged pain control effect and its ability to help people quit the use of opioids.

Because kratom acts on opioid receptors in the same way as opioid itself, the Drug Enforcement Administration (DEA) has always considered that this substance has the risk of addiction. This plant is not classified as a controlled drug, but the Anti Drug Administration lists it as a "drug of concern and chemical."
Dr. Judy McMeekin, Deputy Director of Regulatory Affairs at the US Food and Drug Administration, said at a press conference at the US Department of Justice, "This lockdown highlights our commitment to take proactive action when companies sell products containing dangerous ingredients such as Kratom. We will continue to protect consumers from illegal sales of products that do not comply with FDA regulations.”

A 2022 study found that nearly one-third of people in the United States who use Kratom meet the criteria for Kratom use disorders, including tolerance, withdrawal, smoking cessation failure, and craving. In recent years, research has also linked Kratom with liver injury and death, but it has also been recognized that this plant is a safer pain treatment option than opioid drugs. A review published in the Journal of Clinical Pharmacology in 2021 found that compared to traditional opioid drugs, Kratom can alleviate pain, cause mild euphoria, and have a lower risk of adverse effects on the respiratory and nervous systems. However, its use is associated with hepatotoxicity, seizures and death. A 2020 study also found that Kratom users in the United States are generally more likely to abuse drugs than those who use marijuana, alcohol, or cigarettes.
“If it is ever studied to a point that the FDA puts its thumb of approval on it, it will be in a purified form and there will be data that shows its safety, “ Saids Dr. Alan Kaye, a professor of anesthesiology and pharmacology at LSU in Shreveport, Louisiana.
Currently, the US Food and Drug Administration continues to advise people not to take Kratom.
2026-08-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA issues new guidelines, accelerating the development of personalized medicine
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
India Prepares New Seed and Pesticide Laws
-
Syngenta Caught in Trade Crossfire
-
FDA Tracks Industry Dye Removal
Recommend Reading
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Ample Supply, Acrylonitrile Prices Fluctuate Downward
-
This week, sodium metabisulfite prices rose in China (8.3-8.7)
-
Cost Easing and Weakening Year-End Demand Leave Acrylic Market Stuck in a Standoff
-
July Adipic Acid Market Shows Signs of Recovery
-
Supply-Demand Dynamics Dominate Market Trends; Formic Acid Prices Stabilize and Remain Flat